Table 1 Patient characteristics and correlation between the mean platelet volume and patient and treatment characteristics
Parameter | N (%) | MPV, median (mean ± SD) | p value |
|---|---|---|---|
Sex | |||
Male | 244 (76.5%) | 10.30 (10.23 ± 1.17) | 0.618 |
Female | 75 (23.5%) | 10.20 (10.35 ± 1.15) | |
Age at diagnosis | |||
< 60 | 168 (52.7) | 10.20 (10.22 ± 1.27) | 0.432 |
> 60 | 151 (47.3%) | 10.30 (10.30 ± 1.04) | |
Smoking status | |||
Former or never | 121 (37.9%) | 10.30 (10.22 ± 1.18) | 0.673 |
Current | 191 (59.9%) | 10.30 (10.27 ± 1.16) | |
Missing data | 7 (2.2%) | ||
Alcohol consumption | |||
Former or never | 189 (59.2%) | 10.40 (10.37 ± 1.13) | 0.009 |
Current | 114 (35.7%) | 10.10 (10.03 ± 1.18) | |
Missing data | 16 (5%) | ||
HPV status | |||
Negative | 23 (7.2%) | 10.00 (9.94 ± 1.15) | 0.110 |
Positive | 37 (11.6%) | 10.50 (10.43 ± 0.89) | |
Missing data | 259 (81.2%) | ||
Tumor grade | |||
G 1/2 | 135 (42.3%) | 10.20(10.24 ± 1.12) | 0.270 |
G 3/4 | 180 (56.4%) | 10.40 (10.28 ± 1.21) | |
Missing data | 4 (1.3%) | ||
Tumor stage | |||
T 1/2 | 116 (36.4%) | 10.30 (10.24 ± 1.29) | 0.518 |
T 3/4 | 197 (61.8%) | 10.20 (10.24 ± 1.20) | |
Missing data | 6 (1.9%) | ||
Nodal involvement | |||
N0 | 34 (10.7%) | 10.40 (10.35 ± 1.06) | 0.694 |
N+ | 281 (88.1%) | 10.30 (10.25 ± 1.18) | |
Missing data | 4 (1.3%) | ||
Surgery | |||
Yes | 140 (43.9%) | 10.40 (10.28 ± 1.27) | 0.275 |
No | 179 (56.1%) | 10.20(10.25 ± 1.09) | |
Induction chemotherapy | |||
Yes | 63 (19.7%) | 10.30 (10.27 ± 0.95) | 0.882 |
No | 256 (80.3%) | 10.30 (10.26 ± 1.22) | |
Concomitant chemotherapy | |||
Yes | 87 (27.3%) | 10.05 (9.97 ± 1.61) | 0.141 |
No | 232 (72.7%) | 10.30 (10.37 ± 0.94) | |
Chemo-/immunotherapy | |||
No | 86 (26.9%) | 10.05 (9.97 ± 1.61) | 0.338 |
Erbitux | 38 (11.9%) | 10.35 (10.38 ± 1.05) | |
Cisplatin | 194 (60.8%) | 10.30 (10.37 ± 0.92) | |
RTx technique | |||
3D conformal | 144 (45.1%) | 10.30 (10.24 ± 1.37) | 0.684 |
IMRT | 175 (54.9%) | 10.20 (10.28 ± 0.97) | |
RTx total dose (Gy) | |||
≤ 60 | 61 (19.1%) | 10.2 (10.35 ± 1.05) | 0.779 |
> 60 to < 70 | 75 (23.5%) | 10.40 (10.20 ± 1.42) | |
≥ 70 | 183 (57.4%) | 10.30 (10.26 ± 1.09) | |